Bayer settles with 30 states over Baycol marketing

Share this article:
Bayer has reached a settlement with 30 states to resolve a consumer protection enforcement action over the marketing of Baycol, a cholesterol-lowering drug withdrawn from the market in 2001. The states will share $8 million as part of the judgment.

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization. Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions